| Literature DB >> 29895787 |
Rutuja Dhawde1, Ragini Macaden2, Dhananjaya Saranath3, Kayzad Nilgiriwala4, Appasaheb Ghadge5, Tannaz Birdi6.
Abstract
In the current study, ceftazidime- and ciprofloxacin-resistant—or dual drug-resistant (DDR)—E. coli were isolated from river Mula-Mutha, which flows through rural Pune district and Pune city. The DDR E. coli were further examined for antibiotic resistance to six additional antibiotics. The study also included detection of genes responsible for ceftazidime and ciprofloxacin resistance and vectors for horizontal gene transfer. Twenty-eight percent of the identified DDR E. coli were resistant to more than six antibiotics, with 12% being resistant to all eight antibiotics tested. Quinolone resistance was determined through the detection of qnrA, qnrB, qnrS and oqxA genes, whereas cephalosporin resistance was confirmed through detection of TEM, CTX-M-15, CTX-M-27 and SHV genes. Out of 219 DDR E. coli, 8.2% were qnrS positive and 0.4% were qnrB positive. Percentage of isolates positive for the TEM, CTX-M-15 and CTX-M-27 genes were 32%, 46% and 0.9%, respectively. None of the DDR E. coli tested carried the qnrA, SHV and oqxA genes. Percentage of DDR E. coli carrying Class 1 and 2 integrons (mobile genetic elements) were 47% and 8%, respectively. The results showed that antibiotic resistance genes (ARGs) and integrons were present in the E. coli isolated from the river at points adjoining and downstream of Pune city.Entities:
Keywords: Mula-Mutha river; antibiotic susceptibility testing; antibiotic-resistant genes; integrons
Mesh:
Substances:
Year: 2018 PMID: 29895787 PMCID: PMC6025386 DOI: 10.3390/ijerph15061247
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Distribution of sampling points across Mula and Mutha river.
Sequences of primers, PCR conditions, annealing temperature for amplifying target genes.
| Description | Target Genes | Sequence (5′-3′) | Amplicon Size | Annealing Temp (°C) | Reference |
|---|---|---|---|---|---|
| β-Lactamase | SHV | FP: AGCCGCTTGAGCAAATTAAAC | 713 | 64 | [ |
| TEM | FP: CATTTCCGTGTCGCCCTTATTC | 800 | 62 | ||
| CTX-M-15 | FP: TTAGGAARTGTGCCGCTGYA | 688 | |||
| CTX-M-27 | FP: TCAAGCCTGCCGATCTGGT | 561 | |||
| Plasmid-mediated quinolone resistance |
| FP: AAGGAAGCCGTATGGATATT | 670 | 54 | [ |
|
| FP: CGACCTGAGCGGCACTGAAT | 515 | |||
|
| FP: ACCTTCACCGCTTGCACATT | 571 | |||
|
| FP: CTCGGCGCGATGATGCT | 280 | 64 | [ | |
| Horizontal gene transfer |
| FP: CCTCCCGCACGATGATC | 280 | 55 | [ |
|
| FP: CACGGATATGCGACAAAAAGGT | 788 | 55 | [ |
Dual drug-resistant (DDR) E. coli load at different sites and their antibiotic resistance profile.
| DDR | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sampling Site | CFU (Log10)/100 mL [%] | Resistance to | ||||||||
| Fluro-Quinolone | Cephalosporin | Penicillin | Carbapenem | Amino | β-Lactam and Inhibitor | ESBL | ||||
| CP | CZ | CTX | CPM | AMP | IMP | GN | PIT | CZ + CZL | ||
| (3rd gen) | (3rd gen) | (4th gen) | ||||||||
| KT | 1.99 [2.2] | 94 | 94 | 94 (100) | 75 (79) | 94 (100) | 44 (46) | 16 (17) | 71 (75) | 6 (6) |
| MJ | 3.61 [1.2] | 60 | 60 | 57 (92) | 41 (68) | 60 (100) | 26 (43) | 5 (8) | 33 (55) | 6 (10) |
| SB | 5.09 [1.8] | 65 | 65 | 64 (98) | 49 (75) | 65 (100) | 29 (44) | 12 (18) | 56 (86) | 10 (15) |
| Total | 219 | 215 (98) | 165 (75) | 219 (100) | 99 (45) | 33 (15) | 160 (73) | 22 (10) | ||
Abbreviations: KT: Khamgaontek, MJ: Manjari, SB: Sangam Bridge, CFU: Colony forming units, EBSL: Extended spectrum β-lactamase, CP: Ciprofloxacin, CZ: Cephatazidime, CTX: Cefotaxime, CPM: Cefepime, AMP: Ampicillin, IMP: Imipenem, GN: Gentamicin, PIT: Piperacillin with Tazobactam.
Extended antibiotic resistance profile of DDR E. coli.
| Resistance to Number of Antibiotics | Ciprofloxacin and Ceftazidime (CZ) + Additional Antibiotics | Resistant Isolates (%) |
|---|---|---|
| 3 | AMP/CPM/CTX/PIT | 4 (1.8) |
| 4 | CTX and AMP/IMP/GN/PIT/CPM | 22 (10) |
| 5 | CTX + CPM and AMP/IMP/GN/PIT | 39 (17.8) |
| 6 | CTX + CPM + AMP and IMP/PIT/GN | 63 (28.7) |
| 7 | CTX + CPM + AMP + IMP and GN/PIT | 63 (28.7) |
| 8 | CP + CZ+ CTX + CPM + AMP + IMP + GN + PIT | 28 (12.7) |
Abbreviations: CP: Ciprofloxacin, CZ: Cephatazidime, CTX: Cefotaxime, CPM: Cefepime, AMP: Ampicillin, IMP: Imipenem, GN: Gentamicin, PIT: Piperacillin with Tazobactam.
DDR E. coli (%) detected with specific resistance and/or with integrons.
| Genes | No. of DDR |
|---|---|
| Associated with fluoroquinolone | |
| | 1 (0.4) |
| | 18 (8.2) |
| Associated with β-lactamase | |
| TEM | 70 (32) |
| CTX-M-15 | 100 (46) |
| CTX-M-27 | 2 (0.9) |
| TEM + CTX-M-15 | 22 (10) |
| TEM + CTX-M-27 | 2 (0.9) |
| Associated with fluoroquinolone + β-lactamase | |
| | 10 (4.5) |
| Associated with HGT | |
| | 103 (47) |
| | 18 (8) |
| | 5 (2) |
| Associated with fluoroquinolone + Class 1 integron | |
| | 1 (0.4) |
| | 10 (4.5) |
| Associated with fluoroquinolone + Class 2 integron | |
| | 1 (0.4) |
| Associated with β-lactamase + Class 1 integron | |
| CTX-M-15 | 55 (25) |
| CTX-M-27 | 1 (0.4) |
| TEM | 72 (32) |
| TEM + CTX-M-15 | 14 (6) |
| TEM + CTX-M-27 + | 1 (0.4) |
| Associated with β-lactamase + Class 2 integron | |
| CTX-M-15 | 11 (5) |
| TEM | 7 (3.1) |
| TEM + CTX-M-15 | 3 (1.3) |
| Associated with β-lactamase + Class 1 and Class 2 integron | |
| CTX-M-15 | 3 (1.3) |
| TEM | 4 (1.8) |
| TEM + CTX-M-15 | 2 (0.9) |